What the company does
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. Oncoinvent ASA is based in Oslo, Norway.
What the weekly tape is saying
ONCIN closed the latest completed week at 43.80 NOK. The 4-week return is -12.2% and the 12-week return is -2.9%. Trend Signal is inactive, Market Dynamics is 1.04. Setup signature: Risk-first tape with a 18/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 47.07 NOK
- Vs Trend Line
- -6.9%
- Fair Value
- 536.3 NOK
- Vs Fair Value
- -91.8%
- 52W High
- 100.6 NOK
- 52W Low
- 40.10 NOK
- Drawdown
- -56.5%
- Range Position
- 6.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- NO Healthcare
- Sector Rank
- 8 of 24
- Sector Percentile
- 69.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
NO Healthcare
- Tracked Peers
- 24
- 4W Rank
- 18 of 24
- Avg 1W
- -0.2%
- Avg 4W
- -3.9%
- Trend Breadth
- 33.3%
- Positive MD
- 50.0%
NO Biotechnology
- Tracked Peers
- 11
- 4W Rank
- 8 of 11
- Avg 1W
- -2.2%
- Avg 4W
- -8.1%
- Trend Breadth
- 36.4%
- Positive RS
- 36.4%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.04
- 4W MD Change
- -36.5%
- Relative Strength
- -36.69
- 4W RS Change
- -4.8%
- Expectation
- Negative
- Probability
- 38.99%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 12.1K
- 13W Average
- 21.7K
- 52W Average
- 34.2K
- Vs 13W
- 0.6x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.8%
- 52W Volatility
- 5.9%
- Upside Weeks
- 23
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 3.7% / -5.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- OSL
- Country
- NO
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- NOK
- Market Cap
- 205.6M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 43.80 NOK | 0.2% | 47.07 NOK | 536.3 NOK | 1.04 | -36.69 | 12.1K | Off |
| 5 Jun 2026 | 43.70 NOK | -4.8% | 47.67 NOK | 547.9 NOK | 1.36 | -38.20 | 21.6K | Off |
| 29 May 2026 | 45.90 NOK | -0.2% | 48.81 NOK | 560.8 NOK | 1.48 | -36.16 | 7.4K | Off |
| 22 May 2026 | 46.00 NOK | -7.8% | 49.82 NOK | 576.0 NOK | 1.60 | -39.08 | 18.6K | Off |
| 15 May 2026 | 49.90 NOK | 6.2% | 50.76 NOK | 590.7 NOK | 1.64 | -35.00 | 22.7K | Off |
| 8 May 2026 | 47.00 NOK | -3.7% | 51.47 NOK | 659.7 NOK | 1.72 | -38.75 | 18.2K | Off |
| 1 May 2026 | 48.80 NOK | 3.2% | 52.43 NOK | 728.3 NOK | 1.71 | -39.45 | 19.5K | Off |
| 24 Apr 2026 | 47.30 NOK | -3.1% | 53.34 NOK | 790.4 NOK | 1.70 | -42.00 | 11.5K | Off |
| 17 Apr 2026 | 48.80 NOK | 5.0% | 54.33 NOK | 855.0 NOK | 1.69 | -40.91 | 61.7K | Off |
| 10 Apr 2026 | 46.49 NOK | -0.5% | 55.23 NOK | 1,021 NOK | 1.55 | -47.01 | 14.5K | Off |
| 3 Apr 2026 | 46.72 NOK | 1.6% | 56.05 NOK | 1,190 NOK | 1.33 | -48.30 | 16.6K | Off |
| 27 Mar 2026 | 45.99 NOK | 2.0% | 57.01 NOK | 1,354 NOK | 0.99 | -48.37 | 29.1K | Off |
| 20 Mar 2026 | 45.10 NOK | 1.1% | 58.04 NOK | 1,525 NOK | 0.71 | -50.16 | 28.9K | Off |
| 13 Mar 2026 | 44.60 NOK | 0.1% | 58.95 NOK | 1,697 NOK | 0.51 | -51.12 | 19.0K | Off |